Works by Anderson, Kenneth C.

Results: 265
    1
    2
    3

    Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-024-55308-5
    By:
    • Nadeem, Omar;
    • Aranha, Michelle P.;
    • Redd, Robert;
    • Timonian, Michael;
    • Magidson, Sophie;
    • Lightbody, Elizabeth D.;
    • Alberge, Jean-Baptiste;
    • Bertamini, Luca;
    • Dutta, Ankit K.;
    • El-Khoury, Habib;
    • Bustoros, Mark;
    • Laubach, Jacob P.;
    • Bianchi, Giada;
    • O'Donnell, Elizabeth;
    • Wu, Ting;
    • Tsuji, Junko;
    • Anderson, Kenneth C.;
    • Getz, Gad;
    • Trippa, Lorenzo;
    • Richardson, Paul G.
    Publication type:
    Article
    4

    The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib.

    Published in:
    European Journal of Haematology, 2012, v. 88, n. 5, p. 446, doi. 10.1111/j.1600-0609.2012.01765.x
    By:
    • Richardson, Paul G.;
    • Laubach, Jacob P.;
    • Schlossman, Robert L.;
    • Ghobrial, Irene M.;
    • Redman, Katherine C.;
    • Mckenney, Mary;
    • Warren, Diane;
    • Noonan, Kimberly;
    • Lunde, Laura;
    • Doss, Deborah;
    • Colson, Kathleen;
    • Hideshima, Teru;
    • Mitsiades, Constantine;
    • Munshi, Nikhil C.;
    • Anderson, Kenneth C.
    Publication type:
    Article
    5
    6
    7

    The development of novel targeted therapeutics for treatment of multiple myeloma research roundtable.

    Published in:
    European Journal of Haematology, 2003, v. 70, n. 4, p. 263, doi. 10.1034/j.1600-0609.2003.t01-2-00011.x
    By:
    • Anderson, Kenneth C.;
    • Barlogie, Bart;
    • Berenson, James R.;
    • Dalton, William S.;
    • Adams, Julian;
    • Alsina, Melissa;
    • Bekker, Pirow;
    • Bergsagel, Peter L.;
    • Boise, Lawrence;
    • Chan, Kyle;
    • Chanan-Khan, Asher A.;
    • Comenzo, Raymond;
    • Congdon, Deborah;
    • Croucher, Peter;
    • Epstein, Joshua;
    • Fenton, Robert;
    • Fonseca, Rafael;
    • Gallant, Gilles;
    • Hussein, Mohamad A.;
    • Jagannath, Sundar
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 4, p. 523, doi. 10.1002/ajh.27207
    By:
    • Mao, Xuehan;
    • Yan, Wenqiang;
    • Mery, David;
    • Liu, Jiahui;
    • Fan, Huishou;
    • Xu, Jingyu;
    • Xu, Yan;
    • Sui, Weiwei;
    • Deng, Shuhui;
    • Zou, Dehui;
    • Du, Chenxing;
    • Yi, Shuhua;
    • van Rhee, Frits;
    • Barlogie, Bart;
    • Shaughnessy, John D.;
    • Anderson, Kenneth C.;
    • Zhan, Fenghuang;
    • Qiu, Lugui;
    • An, Gang
    Publication type:
    Article
    18

    Bone marrow biopsy in low‐risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 5, p. E146, doi. 10.1002/ajh.25441
    By:
    • Bustoros, Mark;
    • Kastritis, Efstathios;
    • Sklavenitis‐Pistofidis, Romanos;
    • Liu, Chia‐Jen;
    • Hornburg, Kalvis;
    • Kanellias, Nikolaos;
    • Kim, Geon;
    • Liu, David;
    • Gavriatopoulou, Maria;
    • Marinac, Catherine R.;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Noonan, Kimberly;
    • Reyes, Kaitlen;
    • Rivotto, Bradley;
    • Neuse, Carl Jannes;
    • Ziogas, Dimitrios C.;
    • Laubach, Jacob;
    • Terpos, Evangelos;
    • Anderson, Kenneth C.
    Publication type:
    Article
    19
    20
    21

    Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.

    Published in:
    American Journal of Hematology, 2010, v. 85, n. 9, p. 670, doi. 10.1002/ajh.21788
    By:
    • Ghobrial, Irene M.;
    • Xie, Wanling;
    • Padmanabhan, Swaminathan;
    • Badros, Ashraf;
    • Rourke, Meghan;
    • Leduc, Renee;
    • Chuma, Stacey;
    • Kunsman, Janet;
    • Warren, Diane;
    • Poon, Tiffany;
    • Harris, Brianna;
    • Sam, Amy;
    • Anderson, Kenneth C.;
    • Richardson, Paul G.;
    • Treon, Steven P.;
    • Weller, Edie;
    • Matous, Jeffrey
    Publication type:
    Article
    22

    A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01019-5
    By:
    • Ray, Arghya;
    • Du, Ting;
    • Wan, Xueping;
    • Song, Yan;
    • Pillai, Sindhu C.;
    • Musa, Md. Abu;
    • Fang, Teng;
    • Moore, Jared;
    • Blank, Brian;
    • Du, Xiaohui;
    • Chen, Xi;
    • Warne, Robert;
    • Sutimantanapi, Dena;
    • Lui, Fang;
    • Zavorotinskaya, Tatiana;
    • Colas, Christophe;
    • Friedman, Lori;
    • Junttila, Melissa R.;
    • Chauhan, Dharminder;
    • Anderson, Kenneth C.
    Publication type:
    Article
    23
    24

    Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00791-0
    By:
    • Ogiya, Daisuke;
    • Chyra, Zuzana;
    • Verselis, Sigitas J.;
    • O'Keefe, Morgan;
    • Cobb, Jacquelyn;
    • Abiatari, Ivane;
    • Talluri, Srikanth;
    • Sithara, Anjana Anilkumar;
    • Hideshima, Teru;
    • Chu, Michael P.;
    • Hájek, Roman;
    • Dorfman, David M.;
    • Pilarski, Linda M.;
    • Anderson, Kenneth C.;
    • Adamia, Sophia
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

    Published in:
    Journal of Clinical Investigation, 2013, v. 123, n. 3, p. 1542, doi. 10.1172/JCI66517
    By:
    • Roccaro, Aldo M.;
    • Sacco, Antonio;
    • Maiso, Patricia;
    • Azab, Abdel Kareem;
    • Yu-Tzu Tai;
    • Reagan, Michaela;
    • Azab, Feda;
    • Flores, Ludmila M.;
    • Campigotto, Federico;
    • Weller, Edie;
    • Anderson, Kenneth C.;
    • Scadden, David T.;
    • Ghobrial, Irene M.
    Publication type:
    Article
    45

    Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice.

    Published in:
    2008
    By:
    • Mukherjee, Siddhartha;
    • Raje, Noopur;
    • Schoonmaker, Jesse A.;
    • Liu, Julie C.;
    • Hideshima, Teru;
    • Wein, Marc N.;
    • Jones, Dallas C.;
    • Vallet, Sonia;
    • Bouxsein, Mary L.;
    • Pozzi, Samantha;
    • Chhetri, Shweta;
    • Seo, Y. David;
    • Aronson, Joshua P.;
    • Patel, Chirayu;
    • Fulciniti, Mariateresa;
    • Purton, Louise E.;
    • Glimcher, Laurie H.;
    • Lian, Jane B.;
    • Stein, Gary;
    • Anderson, Kenneth C.
    Publication type:
    journal article
    46
    47
    48
    49
    50